Presentations

08:00

Dysregulated succinate metabolism in M1 macrophages promotes hepatic stellate cell activation and graft fibrosis after pediatric liver transplantation

Zhixin Zhang (CN)

Bio

08:10

Protective anti-HBs thresholds and risk of De Novo hepatitis B after pediatric liver transplantation using anti-HBc–positive donor grafts

Figen Ozcay (TR)

Bio Abstract

08:20

Pediatric organ donation after circulatory death in the United States

Matthew Goldstein (US)

Bio Abstract

08:27

Long-term outcomes of pediatric donation after circulatory death (DCD) liver transplantation: Preliminary results from an European liver transplant registry study

Francesca Albanesi (IT)

Bio Abstract

08:34

Paediatric Lung Transplantation for Pulmonary Hypertension: Excellent Outcomes in a Nationally Centralised Program

Simone Gong (AU)

Bio Abstract

08:41

Identifying an appropriate KDPI max value for paediatric renal recipients

Fiona Hudson (AU)

Bio Abstract

08:46

Measles-Mumps-Rubella vaccination after paediatric heart transplantation

Anne Dipchand (CA)

Bio Abstract

08:51

International Comparisons of Paediatric Organ Donation Systems: a Mixed-Methods Systematic Review of Policies, Practices, and Interventions Associated with Higher Consent Rates

Leah McLaughlin (GB)

Bio Abstract